Gerhard Niederfellner

This inventor holds 14 USPTO granted patents and 13 published patent applications, plus 1 CIPO patent and 8 EPO patents. Top assignees: Hoffmann-La Roche Inc., Roche Glycart Ag, Ludwig-Maximilians-Universitat München. Active years: 2013-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerhard Niederfellner. Retrieved from https://idiyas.com/inventor/gerhard-niederfellner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 (Patent Applications = 13)

% Patents Active = 50.0

CIPO Patents = 1 (Patent Applications = 7)

EPO Patents = 8 (Patent Applications = 16)

Average Co-Inventor Count = 6.3

ph-index = 4

Forward Citations = 34(Granted Patents)

Company Filing History:

10 out of 5,026

Hoffmann-La Roche Inc.

Ludwig-Maximilians-Universitat München

patents

4. 1 out of 3,696

The United States of America, as Represented by the Secretary, Department of Health and Human Services

patents

5. 2 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2013-2023

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11732052 - Bispecific antibody molecules with antigen-transfected T-cells and their use in medicine (2023-08-22),

2. 11618790 - Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery (2023-04-04),

3. 11547748 - Adoptive t-cell therapy (2023-01-10),

4. 10633451 - Bispecific antibody molecules with antigen-transfected T-cells and their use in medicine (2020-04-28),

5. 10626177 - HER3 antigen binding proteins binding to the beta-hairpin of HER3 (2020-04-21),

6. 10364290 - Anti-HER3/HER4 antibodies binding to the beta-hairpin of HER3 and the beta-hairpin of HER4 (2019-07-30),

7. 9840565 - HER1 antigen binding proteins binding to the beta-hairpin of HER1 (2017-12-12),

8. 9783611 - Anti-HER3 antibodies binding to the beta-hairpin of HER3 (2017-10-10),

9. 9725512 - HER3 antibodies binding to the beta-hairpin of HER3 (2017-08-08),

10. 9725511 - Anti-HER3/HER4 antibodies binding to the beta-hairpin of HER3 and the beta-hairpin of HER4 (2017-08-08),

11. 9388222 - [object Object] (2016-07-12),

12. 9346886 - Humanized anti-CDCP1 antibodies (2016-05-24),

13. 8883159 - Antibodies against CDCP1 for the treatment of cancer (2014-11-11),

14. 8394928 - Humanized anti-CDCP1 antibodies (2013-03-12),

Title: The Innovative Journey of Gerhard Niederfellner

Introduction: Gerhard Niederfellner, a pioneering inventor hailing from Oberhausen, Germany, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents: Gerhard Niederfellner's latest patents focus on advancements in renewable energy technologies, particularly in the field of solar power generation and energy storage solutions.

Career Highlights: With a career spanning over two decades, Gerhard Niederfellner has established himself as a leading figure in the renewable energy sector. His innovative solutions have not only revolutionized the industry but have also paved the way for a more sustainable future.

Collaborations: Throughout his career, Gerhard Niederfellner has collaborated with top research institutions and leading companies in the energy sector to further develop and commercialize his inventions. His collaborative efforts have led to the successful implementation of cutting-edge technologies in the market.

Conclusion: Gerhard Niederfellner's passion for innovation and his relentless pursuit of excellence have solidified his position as a visionary inventor in the field of renewable energy. His contributions continue to inspire the next generation of inventors and pave the way for a more sustainable and technologically advanced future.

Profile summary based on public USPTO records.